AT329045B - Verfahren zur herstellung von neuen, basisch substituierten indanderivaten - Google Patents

Verfahren zur herstellung von neuen, basisch substituierten indanderivaten

Info

Publication number
AT329045B
AT329045B AT255373A AT255373A AT329045B AT 329045 B AT329045 B AT 329045B AT 255373 A AT255373 A AT 255373A AT 255373 A AT255373 A AT 255373A AT 329045 B AT329045 B AT 329045B
Authority
AT
Austria
Prior art keywords
indanderivatives
new basic
manufacturing new
basic substituted
substituted
Prior art date
Application number
AT255373A
Other languages
English (en)
Other versions
ATA255373A (de
Inventor
Barbro Kar Goransson-Dahlander
Nils Ake Jonsson
Ferenc Merenyi
Original Assignee
Kabi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Ab filed Critical Kabi Ab
Priority to AT76775A priority Critical patent/AT333743B/de
Priority to AT76875A priority patent/AT333744B/de
Publication of ATA255373A publication Critical patent/ATA255373A/de
Application granted granted Critical
Publication of AT329045B publication Critical patent/AT329045B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/657—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
    • C07C49/665—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system
    • C07C49/675—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system having three rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/687—Unsaturated compounds containing a keto groups being part of a ring containing halogen
    • C07C49/697—Unsaturated compounds containing a keto groups being part of a ring containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/46—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings, e.g. cyclohexylphenylacetic acid
    • C07C57/50—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings, e.g. cyclohexylphenylacetic acid containing condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/62—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings and other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT255373A 1972-03-24 1973-03-22 Verfahren zur herstellung von neuen, basisch substituierten indanderivaten AT329045B (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AT76775A AT333743B (de) 1972-03-24 1975-02-03 Verfahren zur herstellung von neuen, basisch substituierten indanderivaten
AT76875A AT333744B (de) 1972-03-24 1975-02-03 Verfahren zur herstellung von neuen, basisch substituierten indenderivaten

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7203905A SE371190B (de) 1972-03-24 1972-03-24

Publications (2)

Publication Number Publication Date
ATA255373A ATA255373A (de) 1975-07-15
AT329045B true AT329045B (de) 1976-04-26

Family

ID=20263107

Family Applications (1)

Application Number Title Priority Date Filing Date
AT255373A AT329045B (de) 1972-03-24 1973-03-22 Verfahren zur herstellung von neuen, basisch substituierten indanderivaten

Country Status (12)

Country Link
US (1) US4172093A (de)
JP (1) JPS599540B2 (de)
AT (1) AT329045B (de)
CA (1) CA1032165A (de)
CH (4) CH621110A5 (de)
DE (1) DE2314636C2 (de)
DK (1) DK138598B (de)
FI (1) FI57253C (de)
FR (1) FR2177929B1 (de)
GB (1) GB1421208A (de)
NO (1) NO138628C (de)
SE (1) SE371190B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1109066A (en) * 1977-08-05 1981-09-15 Aake N. Joensson Geminally disubstituted indene derivatives
CH641147A5 (de) * 1979-01-17 1984-02-15 Sandoz Ag 3-amino-2-hydroxypropoxyaryl-derivat, seine herstellung und dieses enthaltende heilmittel.
CH647235A5 (de) * 1980-02-13 1985-01-15 Sandoz Ag 4-(2,2-dialkylindan-1-yliden)piperidin derivate, ihre herstellung und verwendung.
IL103106A (en) * 1991-09-25 1998-06-15 Sanofi Elf Sites of tynocyclopentanone oximes, their preparation and pharmaceutical preparations containing them
GB9309621D0 (en) * 1993-05-11 1993-06-23 Wellcome Found Amide derivatives and their therapeutic use
US5877218A (en) * 1994-01-10 1999-03-02 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
MY113062A (en) * 1994-05-10 2001-11-30 The Wellcome Foundation Ltd Amide derivatives and their therapeutic use
PT966435E (pt) 1996-12-18 2005-06-30 Yissum Res Dev Co Derivados aminoindano
US6124284A (en) * 1998-07-16 2000-09-26 Glaxo Wellcome Inc. Bicyclic amide derivatives and their use as muscle relaxants
US6737547B1 (en) 1998-12-31 2004-05-18 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using N-acyl-1H-aminoindenes
US20040010038A1 (en) * 2002-02-27 2004-01-15 Eran Blaugrund Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors
GB0328906D0 (en) 2003-12-12 2004-01-14 Syngenta Participations Ag Chemical compounds
US20070135518A1 (en) * 2005-12-09 2007-06-14 Marta Weinstock-Rosin Use of low-dose ladostigil for neuroprotection
CA2634166C (en) * 2005-12-09 2016-03-29 Marta Weinstock-Rosin Use of low-dose ladostigil for neuroprotection
TW200744576A (en) * 2006-02-24 2007-12-16 Teva Pharma Propargylated aminoindans, processes for preparation, and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1007323B (de) * 1956-04-13 1957-05-02 Schering Ag Verfahren zur Herstellung von 1-Aminoindanen mit coronargefaesserweiternder Wirkung
US3308157A (en) * 1964-08-07 1967-03-07 Colgate Palmolive Co N-(benzocyclobutene-1-loweralkyl)-carboxylic acid amides
US3360435A (en) * 1964-09-15 1967-12-26 Mead Johnson & Co Treatment of depressed states
US3553093A (en) * 1965-03-19 1971-01-05 Xerox Corp Color photoelectrophoretic imaging process
GB1139135A (en) * 1965-10-01 1969-01-08 Kefalas As Aminoalkyl-substituted indanes and pharmaceutical compositions containing them
CH554828A (de) * 1968-04-23 1974-10-15 Ciba Geigy Ag Verfahren zur herstellung von neuen aminoalkyl-(bzw. 1aminoalkyliden-) benzcycloalkan-2-spirocycloaliphatischen verbindungen.
US3657440A (en) * 1968-04-23 1972-04-18 Ciba Geigy Corp Aminoalkyl-spirocycloalkanes as analgetic agents

Also Published As

Publication number Publication date
CA1032165A (en) 1978-05-30
NO138628C (no) 1978-10-11
ATA255373A (de) 1975-07-15
FI57253B (fi) 1980-03-31
CH626044A5 (de) 1981-10-30
NO138628B (no) 1978-07-03
DK138598C (de) 1979-03-26
CH622769A5 (de) 1981-04-30
DE2314636A1 (de) 1973-10-04
FR2177929B1 (de) 1976-10-22
FI57253C (fi) 1980-07-10
JPS599540B2 (ja) 1984-03-03
SE371190B (de) 1974-11-11
AU5365173A (en) 1974-09-26
GB1421208A (en) 1976-01-14
DK138598B (da) 1978-10-02
DE2314636C2 (de) 1986-09-11
CH621110A5 (de) 1981-01-15
JPS495957A (de) 1974-01-19
US4172093A (en) 1979-10-23
CH626045A5 (de) 1981-10-30
FR2177929A1 (de) 1973-11-09

Similar Documents

Publication Publication Date Title
AT334638B (de) Verfahren zur herstellung von neuen, linearen polyestern
AT327181B (de) Verfahren zur herstellung von neuen phenylindanestern
AT329045B (de) Verfahren zur herstellung von neuen, basisch substituierten indanderivaten
ATA993573A (de) Verfahren zur herstellung von neuen cephalosporinathern
AT325605B (de) Verfahren zur herstellung von neuen alpha-phenylindolderivaten
AT330955B (de) Verfahren zur herstellung von neuen beta-lactamen
AT328078B (de) Verfahren zur herstellung von neuen cyanomethylthioacetylcephalosporinen
AT327904B (de) Verfahren zur herstellung von neuen 2,6-diamino-dihydropyridinen
ATA910173A (de) Verfahren zur herstellung von neuen 11,12-secoprostaglandinen
AT323189B (de) Verfahren zur herstellung von neuen lactamen
AT331805B (de) Verfahren zur herstellung von neuen triazinobenzimidazolen
AT326841B (de) Verfahren zur herstellung von neuen 15alfa,16alfa-methylen-4-pregnenen
AT333740B (de) Verfahren zur herstellung von neuen indanderivaten
AT334879B (de) Verfahren zur herstellung von neuen arylathern
AT322104B (de) Verfahren zur herstellung von neuen pyrono-rifamycinen
AT327413B (de) Verfahren zur herstellung von neuen 15alpha,16alpha-methylen-4-ostren-17beta-olen
ATA76775A (de) Verfahren zur herstellung von neuen, basisch substituierten indanderivaten
AT338229B (de) Verfahren zur herstellung von neuen aldehydolactonen
AT323885B (de) Verfahren zur herstellung von neuen 3-formylrifamycinazinen
ATA1039174A (de) Verfahren zur herstellung von neuen 15alfa,16alfa-methylen-4-ostren-17beta-olen
AT325048B (de) Verfahren zur herstellung von neuen dihydro - 2 - aminoisochinolinen
AT329533B (de) Verfahren zur herstellung von neuen cyclopentanalen
ATA76875A (de) Verfahren zur herstellung von neuen, basisch substituierten indenderivaten
ATA793675A (de) Verfahren zur herstellung von neuen aldehydolactonen
ATA646772A (de) Verfahren zur herstellung von neuen substituierten n-carbamoyloxyphenylcarbamaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee